Nuclear Medicine Market Top Key Players SWOT Analysis PESTLE Analysis | Lantheus Holdings, Inc. (Lantheus Medical Imaging, Inc.), Novartis AG (Advanced Accelerator Applications S.A.), Otsuka Holdings Co., Ltd. (ABX advanced biochemical compounds GmbH)

The Asia-Pacific nuclear medicine market was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.

Radiopharmaceuticals are pharmaceutical formulations comprise radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance used in the treatment of cancer and cardiac & neurological disorders.

Get our sample copy of the report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1796

Moreover, nuclear medicines of modality, SPECT and PET work as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. Applications such as lymphoma and bone metastasis use radiopharmaceuticals, also known as nuclear medicines.

F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures, while I-131, Ir192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedure. More convenient therapeutic radiopharmaceuticals for oncology and cancer treatment replace the conventional chemotherapy methods to open up new avenues in the radiopharmaceuticals market.
The market is currently in its growth stage driven by increase in the number of cancer cases in the Asia-Pacific region and the surge awareness about nuclear medicine. Convenience of treatment with minimally invasive techniques attracts more patients toward the radiopharmaceuticals mode of treatment as compared to chemotherapy.

The factors that drive the radiopharmaceuticals industry include increase in incidence of cardiac patients and adoption of clear imaging technique, with the help of diagnostic equipment such as PET and SPECT. The factors that hinder the growth of the market include supply shortages, logistical difficulties, and limited number of trained medical personnel.

Get 20% Off On Various License Types When Buy Now At: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1796

The nuclear medicine market is categorized into type, modality, application, and end-user. On the basis of type, the market is segmented into diagnostics, therapeutics, and biochemistry research. The diagnostics segment led the market in 2020, and is anticipated to continue this trend during the forecast period, owing to the surge in prevalence of cancer that require early diagnosis for appropriate treatment could be provided in the Asia-Pacific region. Furthermore, rise in incidence of cardiac patients and clear imaging technique with the help of diagnostic equipment such as PET and SPECT is projected to help the diagnostics segment gain traction.

List of key players profiled in the report
- Bracco S.P.A. (Bracco Imaging S.P.A.)
- Bwx Technologies, Inc. (Nordion, Inc.)
- Cardinal Health, Inc.
- Danaher Corporation (GE Healthcare)
- FUJIFILM Toyama Chemical Co., Ltd. (FUJIFILM Holdings Corporation)
- Ion Beam Applications (Ion Beam Applications, SA)
- Lantheus Holdings, Inc. (Lantheus Medical Imaging, Inc.)
- Novartis AG (Advanced Accelerator Applications S.A.)
- Otsuka Holdings Co., Ltd. (ABX advanced biochemical compounds GmbH)
- Siemens Healthcare GmbH

KEY BENEFITS FOR STAKEHOLDERS

- The study provides an in-depth analysis of the Asia-Pacific nuclear medicine market size along with the current trends and future estimations to elucidate the imminent investment pockets
- It offers market analysis from 2021 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the Asia-Pacific nuclear medicine market growth

KEY MARKET SEGMENTS

By Type
- Diagnostics
- Therapeutics
- Biochemistry Research

By Modality
- SPECT
- PET
- Beta Emitters
- Alpha Emitters
- Brachytherapy
- Others

By Application
- Oncology
- Cardiology
- Thyroid
- Neurology
- Others

By End User
- Hospitals & Diagnostics Centers
- Research Institutes

By Country
- Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Rest of Asia-Pacific

Download Free Sample Report Now @ https://reportocean.com/industry-verticals/sample-request?report_id=AMR1796

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES
Tel: +1 888 212 3539 (US - TOLL FREE)
Website: https://www.reportocean.com/

About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today's competitive environment. Report Ocean is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.

This release was published on openPR.